Paediatric Antiseizure Medication Use and Costs in France
A recent study looked at how anti-seizure medications (ASMs) are used and their costs for children in France from 2014 to 2023.
This hub covers epilepsy devices and neuromodulation like VNS, RNS, and DBS, which are treatments that can reduce seizures when meds arenβt enough. Plain-language research summaries plus real-life pros/cons.
Some are used more often in adults, but pediatric use depends on the device, the case, and specialist guidance.
Often gradually. Improvement can build over months as settings are optimized.
Sometimes medication can be reduced, but many people still use meds alongside a device.
Sometimes yes, with device-specific rules. Always check the exact device guidelines first.
A recent study looked at how anti-seizure medications (ASMs) are used and their costs for children in France from 2014 to 2023.
Researchers studied a technique called external trigeminal nerve stimulation (eTNS) to see how it might help with various neuropsychiatric disorders.
The I-ACQUIRE Phase 3 trial studied infants and toddlers aged 8 to 36 months who had experienced perinatal arterial ischemic stroke, which can lead to movement difficulties and other disabilities.
Researchers studied 47 patients with drug-resistant temporal lobe epilepsy and hippocampal sclerosis who were undergoing surgery to help control their seizures.
Researchers studied the effects of a treatment called continuous hippocampal deep brain stimulation (Hip-DBS) on memory and cognitive function in patients with drug-resistant temporal lobe epilepsy (TLE).
This study looked at the role of genetic testing in children with expressive language delay (ELD), a condition where kids have trouble expressing themselves verbally.
Researchers studied brain MRI scans of 139 children with specific genetic types of epilepsy linked to four genes: SCN1A, SCN2A, SCN3A, and SCN8A.
This study looked at febrile seizures (FSs) in young children, specifically those aged 6 months to 3 years, who were treated at a pediatric hospital in Shanghai between April 2021 and March 2023.
Researchers studied the safety of deep brain stimulation (DBS), a surgical treatment used for conditions like epilepsy, by comparing it to other common elective surgeries.